Clinical Trial

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Name: Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) — clinical trial record (NCT05917106)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To conduct prospective studies to confirm the value of circulating tumor DNA and its abnormal methylation in longitudinal monitoring of patients undergoing kidney cancer surgery.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2023-06-15; most recent amendment 2025-12-04.

Trial Details

NCT Number	NCT05917106
Lead Sponsor	Jinling Hospital, China
Conditions	Carcinoma, Renal Cell Carcinoma, RCC, Kidney Neoplasms, Kidney Cancer
Enrollment	450 participants
Start Date	2022-12-26
Primary Completion	2028-06 (estimated)
Study Completion	2030-06 (estimated)
Updated on ClinicalTrials.gov	2025-12-11